
Insulin Aspart (100IU/ml)
Active composition
Insulin Aspart facilitates glucose transport into cells by binding to insulin receptors, promoting cellular uptake of glucose.
Medical applications
NovoRapid Penfill is a rapid-acting insulin analogue formulation, featuring Insulin Aspart at a concentration of 100IU/ml. This 3ml pre-filled insulin pen provides a consistent and predictable insulin delivery to help manage blood glucose levels in patients with diabetes mellitus. NovoRapid Penfill's onset of action is within 10-20 minutes, with peak effect occurring between 1-2 hours post-injection, and duration lasting up to 4-6 hours. It is designed for bolus injections before meals or as replacement for missed meals, aiding in the maintenance of near-normal glucose levels. NovoRapid Penfill is recommended for patients with type 1 diabetes, type 2 diabetes on insulin therapy, and those undergoing intensive insulin therapy. As with all insulin therapies, careful monitoring of blood glucose levels, injection sites, and proper storage is essential to ensure optimal safety and efficacy.
How to use NovoRapid Solution for Injection Your doctor or nurse will guide you how to use this medicine.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is unsafe to consume alcohol with NovoRapid Penfill (3ml Each).
High Risk
NovoRapid Penfill (3ml Each) is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Medical Advice
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
NovoRapid Penfill (3ml Each) should be used with caution in patients with liver disease. Dose adjustment of NovoRapid Penfill (3ml Each) may be needed. Please consult your doctor. Frequent and regular monitoring of blood glucose levels is advised.
Regular Checkup
NovoRapid Penfill (3ml Each) is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Consult Doctor
NovoRapid Penfill (3ml Each) should be used with caution in patients with kidney disease. Dose adjustment of NovoRapid Penfill (3ml Each) may be needed. Please consult your doctor. Regular monitoring of blood glucose levels is recommended for dose adjustment.
Regular Checkup
0 reviews for NovoRapid Penfill (3ml Each)

Insulin Aspart (100IU/ml)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
Insulin Aspart facilitates glucose transport into cells by binding to insulin receptors, promoting cellular uptake of glucose.
Medical applications
NovoRapid Penfill is a rapid-acting insulin analogue formulation, featuring Insulin Aspart at a concentration of 100IU/ml. This 3ml pre-filled insulin pen provides a consistent and predictable insulin delivery to help manage blood glucose levels in patients with diabetes mellitus. NovoRapid Penfill's onset of action is within 10-20 minutes, with peak effect occurring between 1-2 hours post-injection, and duration lasting up to 4-6 hours. It is designed for bolus injections before meals or as replacement for missed meals, aiding in the maintenance of near-normal glucose levels. NovoRapid Penfill is recommended for patients with type 1 diabetes, type 2 diabetes on insulin therapy, and those undergoing intensive insulin therapy. As with all insulin therapies, careful monitoring of blood glucose levels, injection sites, and proper storage is essential to ensure optimal safety and efficacy.
How to use NovoRapid Solution for Injection Your doctor or nurse will guide you how to use this medicine.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is unsafe to consume alcohol with NovoRapid Penfill (3ml Each).
High Risk
NovoRapid Penfill (3ml Each) is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Medical Advice
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
NovoRapid Penfill (3ml Each) should be used with caution in patients with liver disease. Dose adjustment of NovoRapid Penfill (3ml Each) may be needed. Please consult your doctor. Frequent and regular monitoring of blood glucose levels is advised.
Regular Checkup
NovoRapid Penfill (3ml Each) is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Consult Doctor
NovoRapid Penfill (3ml Each) should be used with caution in patients with kidney disease. Dose adjustment of NovoRapid Penfill (3ml Each) may be needed. Please consult your doctor. Regular monitoring of blood glucose levels is recommended for dose adjustment.
Regular Checkup
0 reviews for NovoRapid Penfill (3ml Each)











